- Clinical Trials
- January 2024
- 60 Pages
Global
From €1195EUR$1,250USD£1,000GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1195EUR$1,250USD£1,000GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1434EUR$1,500USD£1,200GBP
- Report
- May 2023
- 147 Pages
Global
From €4732EUR$4,949USD£3,961GBP
- Report
- February 2024
- 120 Pages
Global
From €4541EUR$4,750USD£3,802GBP
- Report
- February 2024
- 110 Pages
Global
From €4541EUR$4,750USD£3,802GBP
- Report
- July 2021
- 111 Pages
Global
From €4541EUR$4,750USD£3,802GBP
- Report
- November 2023
- 250 Pages
Global
€4776EUR$4,995USD£3,998GBP
- Report
- January 2024
- 91 Pages
Global
From €3500EUR$3,921USD£3,032GBP
- Report
- November 2021
- 600 Pages
Global
From €3824EUR$4,000USD£3,201GBP
- Report
- December 2023
- 279 Pages
Global
From €3528EUR$3,690USD£2,953GBP

Capsaicin is a naturally occurring compound found in chili peppers, and is used in the form of a topical analgesic to treat a variety of conditions, including arthritis, muscle pain, and nerve pain. It works by blocking the transmission of pain signals to the brain, and is often used in combination with other analgesics to provide relief. Capsaicin is available in a variety of forms, including creams, gels, and patches. It is also available in combination with other analgesics, such as ibuprofen and acetaminophen.
The capsaicin market is a growing segment of the analgesics market, with increasing demand for capsaicin-based products due to their effectiveness in treating pain. The market is expected to continue to grow in the coming years, driven by the increasing prevalence of chronic pain and the growing awareness of the benefits of capsaicin-based products.
Some companies in the capsaicin market include GlaxoSmithKline, Johnson & Johnson, Pfizer, and Merck. Show Less Read more